Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Jane Jooyun Kim, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture
Other Positions
Title
Institution
Department

Overview
Dr. Kim's research focuses on the development and application of mathematical modeling methods to evaluate health policy issues related to women's health. She has developed and used models to perform cost-effectiveness analyses of cervical cancer screening strategies in the U.S., Europe, Hong Kong, and less developed regions.

Her methodological interests include integrating different methods of operations research to inform health decision-making in low-resource settings, such as packaging health services at opportune moments and quantifying the impacts of budget and human resource constraints on program effectiveness and feasibility.

She has won awards for her presentations at annual meetings held by the Society for Medical Decision Making and the International Papillomavirus Society.

Dr. Kim holds a Master's degree in Health Policy and Management from the Harvard School of Public Health (2001) and a Ph.D. in Health Policy and Decision Sciences from Harvard University (2005).

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01CA253912 (KIM, JANE JOOYUN) Sep 8, 2020 - Aug 31, 2025
    NIH
    Comparative Modeling to Inform Cervical Cancer Control Policies
    Role: Principal Investigator
  2. U01CA199334 (KIM, JANE JOOYUN) Sep 9, 2015 - Aug 31, 2021
    NIH
    Comparative Modeling to Inform Cervical Cancer Control Policies
    Role: Co-Principal Investigator
  3. R01CA160744 (KIM, JANE JOOYUN) Jun 1, 2012 - Mar 31, 2017
    NIH
    Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Portnoy A, Sweet S, Desalegn D, Memirie ST, Kim JJ, Verguet S. Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study. Health Policy Plan. 2021 May 04. PMID: 33942850.
    Citations:    Fields:    
  2. Campos NG, Scarinci IC, Tucker L, Peral S, Li Y, Regan MC, Sy S, Castle PE, Kim JJ. Cost-Effectiveness of Offering Cervical Cancer Screening with HPV Self-Sampling among African-American Women in the Mississippi Delta. Cancer Epidemiol Biomarkers Prev. 2021 Mar 26. PMID: 33771846.
    Citations:    Fields:    
  3. Burger EA, Jansen EE, Killen J, Kok IM, Smith MA, Sy S, Dunnewind N, G Campos N, Haas JS, Kobrin S, Kamineni A, Canfell K, Kim JJ. Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen. 2021 Mar 17; 9691413211001097. PMID: 33730899.
    Citations: 1     Fields:    
  4. Kim JJ, Simms KT, Killen J, Smith MA, Burger EA, Sy S, Regan C, Canfell K. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis. PLoS Med. 2021 Mar; 18(3):e1003534. PMID: 33705382.
    Citations: 1     Fields:    
  5. Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, Smith MA, Sy S, Nygård M, Kim JJ, Burger EA. Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Prev Med. 2021 Mar; 144:106276. PMID: 33678239.
    Citations:    Fields:    
  6. Campos NG, Demarco M, Bruni L, Desai KT, Gage JC, Adebamowo SN, de Sanjose S, Kim JJ, Schiffman M. A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer. Prev Med. 2021 Mar; 144:106438. PMID: 33678235.
    Citations:    Fields:    
  7. Scarinci IC, Li Y, Tucker L, Campos NG, Kim JJ, Peral S, Castle PE. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. Prev Med. 2021 01; 142:106358. PMID: 33338505.
    Citations:    Fields:    
  8. Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020 10; 24(4):426. PMID: 32732648.
    Citations:    Fields:    Translation:Humans
  9. Fogelberg S, Clements MS, Pedersen K, Sy S, Sparén P, Kim JJ, Burger EA. Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden. PLoS One. 2020; 15(9):e0239611. PMID: 32997696.
    Citations:    Fields:    Translation:HumansPHPublic Health
  10. Burger EA, de Kok IMCM, Groene E, Killen J, Canfell K, Kulasingam S, Kuntz KM, Matthijsse S, Regan C, Simms KT, Smith MA, Sy S, Alarid-Escudero F, Vaidyanathan V, van Ballegooijen M, Kim JJ. Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis. J Natl Cancer Inst. 2020 09 01; 112(9):955-963. PMID: 31821501.
    Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
  11. Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021 Feb 15; 148(4):932-940. PMID: 32706907.
    Citations: 2     Fields:    
  12. Simms KT, Yuill S, Killen J, Smith MA, Kulasingam S, de Kok IMCM, van Ballegooijen M, Burger EA, Regan C, Kim JJ, Canfell K. Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions. Gynecol Oncol. 2020 09; 158(3):710-718. PMID: 32723676.
    Citations:    Fields:    Translation:Humans
  13. de Kok IMCM, Burger EA, Naber SK, Canfell K, Killen J, Simms K, Kulasingam S, Groene E, Sy S, Kim JJ, van Ballegooijen M. The Impact of Different Screening Model Structures on Cervical Cancer Incidence and Mortality Predictions: The Maximum Clinical Incidence Reduction (MCLIR) Methodology. Med Decis Making. 2020 05; 40(4):474-482. PMID: 32486894.
    Citations:    Fields:    Translation:Humans
  14. Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020 04; 24(2):102-131. PMID: 32243307.
    Citations: 20     Fields:    Translation:Humans
  15. Bernecker SL, Zuromski KL, Curry JC, Kim JJ, Gutierrez PM, Joiner TE, Kessler RC, Nock MK, Rudd MD, Bryan CJ. Economic Evaluation of Brief Cognitive Behavioral Therapy vs Treatment as Usual for Suicidal US Army Soldiers. JAMA Psychiatry. 2020 03 01; 77(3):256-264. PMID: 31774485.
    Citations: 2     Fields:    Translation:Humans
  16. Burger EA, Smith MA, Killen J, Sy S, Simms KT, Canfell K, Kim JJ. Projected time to elimination of cervical cancer in the USA: a comparative modelling study. Lancet Public Health. 2020 04; 5(4):e213-e222. PMID: 32057315.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  17. Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, Burger EA, Martin D, Nguyen DTN, Bénard É, Sy S, Regan C, Drolet M, Gingras G, Laprise JF, Torode J, Smith MA, Fidarova E, Trapani D, Bray F, Ilbawi A, Broutet N, Hutubessy R. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 02 22; 395(10224):591-603. PMID: 32007142.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  18. Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S, Regan C, Keane A, Caruana M, Nguyen DTN, Smith MA, Laprise JF, Jit M, Alary M, Bray F, Fidarova E, Elsheikh F, Bloem PJN, Broutet N, Hutubessy R. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020 02 22; 395(10224):575-590. PMID: 32007141.
    Citations: 30     Fields:    Translation:HumansPHPublic Health
  19. Campos NG, Alfaro K, Maza M, Sy S, Melendez M, Masch R, Soler M, Conzuelo-Rodriguez G, Gage JC, Alonzo TA, Castle PE, Felix JC, Cremer M, Kim JJ. The cost-effectiveness of human papillomavirus self-collection among cervical cancer screening non-attenders in El Salvador. Prev Med. 2020 02; 131:105931. PMID: 31765712.
    Citations:    Fields:    Translation:HumansCells
  20. Portnoy A, Campos NG, Sy S, Burger EA, Cohen J, Regan C, Kim JJ. Impact and Cost-Effectiveness of Human Papillomavirus Vaccination Campaigns. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):22-30. PMID: 31666282.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  21. Canfell K, Kim JJ, Kulasingam S, Berkhof J, Barnabas R, Bogaards JA, Campos N, Jennett C, Sharma M, Simms KT, Smith MA, Velentzis LS, Brisson M, Jit M. HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control. Papillomavirus Res. 2019 12; 8:100184. PMID: 31505258.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  22. Wanis KN, Maleyeff L, Van Koughnett JAM, H D Colquhoun P, Ott M, Leslie K, Hernandez-Alejandro R, Kim JJ. Health and Economic Impact of Intensive Surveillance for Distant Recurrence After Curative Treatment of Colon Cancer: A Mathematical Modeling Study. Dis Colon Rectum. 2019 07; 62(7):872-881. PMID: 31188189.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  23. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Masch R, Cremer M, Kim JJ. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador. Int J Gynaecol Obstet. 2019 Apr; 145(1):40-46. PMID: 30702142.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  24. Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Paul Doria-Rose V. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort. Int J Cancer. 2019 03 15; 144(6):1460-1473. PMID: 30353911.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  25. Campos NG, Tsu V, Jeronimo J, Regan C, Resch S, Clark A, Sy S, Kim JJ. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis. Int J Cancer. 2019 02 15; 144(4):687-696. PMID: 30132850.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  26. Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. . 2018 10 01; 79(2):195-205. PMID: 29916959.
    Citations: 6     Translation:HumansPHPublic Health
  27. Burger EA, Dyer MA, Sy S, Palefsky JM, de Pokomandy A, Coutlee F, Silverberg MJ, Kim JJ. Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. . 2018 09 01; 79(1):10-19. PMID: 29757775.
    Citations:    Translation:HumansCells
  28. Kim JJ, Burger EA, Regan C, Sy S. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force. JAMA. 2018 08 21; 320(7):706-714. PMID: 30140882.
    Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
  29. Cook EE, Venkataramani AS, Kim JJ, Tamimi RM, Holmes MD. Legislation to Increase Uptake of HPV Vaccination and Adolescent Sexual Behaviors. Pediatrics. 2018 09; 142(3). PMID: 30104422.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  30. Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, Ogilvie GS, Kim JJ, Campos NG. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. BMJ Open. 2018 06 12; 8(6):e020484. PMID: 29895648.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  31. Burger EA, Campos NG, Sy S, Regan C, Kim JJ. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Vaccine. 2018 08 06; 36(32 Pt A):4823-4829. PMID: 29807710.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  32. Castle PE, Wheeler CM, Campos NG, Sy S, Burger EA, Kim JJ. Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S. Prev Med. 2018 06; 111:177-179. PMID: 29548787.
    Citations:    Fields:    Translation:HumansPHPublic Health
  33. Cook EE, Gershman ST, Kim JJ, Tamimi RM, Klevens RM, Holmes MD. Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer. Cancer Causes Control. 2018 05; 29(4-5):435-443. PMID: 29497883.
    Citations: 2     Fields:    Translation:HumansCells
  34. Pedersen K, Fogelberg S, Thamsborg LH, Clements M, Nygård M, Kristiansen IS, Lynge E, Sparén P, Kim JJ, Burger EA. An overview of cervical cancer epidemiology and prevention in Scandinavia. Acta Obstet Gynecol Scand. 2018 Jul; 97(7):795-807. PMID: 29388202.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  35. Pedersen K, Burger EA, Nygård M, Kristiansen IS, Kim JJ. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines. Eur J Cancer. 2018 03; 91:68-75. PMID: 29335156.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  36. Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy Plan. 2017 Dec 01; 32(10):1491. PMID: 28973511.
    Citations:    Fields:    
  37. Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study. BMC Cancer. 2017 Nov 25; 17(1):791. PMID: 29178896.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  38. Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164. PMID: 29150480.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  39. Burger EA, Kim JJ, Sy S, Castle PE. Age of Acquiring Causal Human Papillomavirus (HPV) Infections: Leveraging Simulation Models to Explore the Natural History of HPV-induced Cervical Cancer. Clin Infect Dis. 2017 Sep 15; 65(6):893-899. PMID: 28531261.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  40. Campos NG, Tsu V, Jeronimo J, Njama-Meya D, Mvundura M, Kim JJ. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting. Health Policy Plan. 2017 Sep 01; 32(7):956-968. PMID: 28369405.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  41. Burger EA, Pedersen K, Sy S, Kristiansen IS, Kim JJ. Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway. Br J Cancer. 2017 Sep 05; 117(6):783-790. PMID: 28772279.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  42. Campos NG, Tsu V, Jeronimo J, Mvundura M, Kim JJ. Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings. Cancer Med. 2017 Aug; 6(8):2008-2014. PMID: 28707435.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  43. Campos NG, Jeronimo J, Tsu V, Castle PE, Mvundura M, Kim JJ. The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries. Cancer Epidemiol Biomarkers Prev. 2017 10; 26(10):1500-1510. PMID: 28710075.
    Citations: 5     Fields:    Translation:Humans
  44. Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua. BMJ Open. 2017 06 15; 7(6):e015048. PMID: 28619772.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  45. Menzies NA, Soeteman DI, Pandya A, Kim JJ. Bayesian Methods for Calibrating Health Policy Models: A Tutorial. Pharmacoeconomics. 2017 Jun; 35(6):613-624. PMID: 28247184.
    Citations: 11     Fields:    Translation:Humans
  46. Benard VB, Castle PE, Jenison SA, Hunt WC, Kim JJ, Cuzick J, Lee JH, Du R, Robertson M, Norville S, Wheeler CM. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era. JAMA Oncol. 2017 Jun 01; 3(6):833-837. PMID: 27685805.
    Citations: 25     Fields:    Translation:Humans
  47. Mezei AK, Armstrong HL, Pedersen HN, Campos NG, Mitchell SM, Sekikubo M, Byamugisha JK, Kim JJ, Bryan S, Ogilvie GS. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. Int J Cancer. 2017 08 01; 141(3):437-446. PMID: 28297074.
    Citations: 23     Fields:    Translation:Humans
  48. Campos NG, Tsu V, Jeronimo J, Mvundura M, Lee K, Kim JJ. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings. Int J Cancer. 2017 03 15; 140(6):1293-1305. PMID: 27925175.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  49. Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst. 2017 Feb 01; 109(2):1-9. PMID: 28376222.
    Citations:    
  50. Sharma M, Seoud M, Kim JJ. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon. Vaccine. 2017 01 23; 35(4):564-569. PMID: 28017434.
    Citations: 2     Fields:    Translation:Humans
  51. Kim JJ, Burger EA, Sy S, Campos NG. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus. J Natl Cancer Inst. 2017 02; 109(2). PMID: 27754955.
    Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
  52. Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, Luciani S, Murokora D, Ngoma T, Qiao Y, Quinn M, Sankaranarayanan R, Sasieni P, Schmeler KM, Shastri SS. Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline. J Glob Oncol. 2017 Oct; 3(5):635-657. PMID: 29094101.
    Citations: 30     Fields:    
  53. Campos NG, Sharma M, Clark A, Kim JJ, Resch SC. Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries. PLoS One. 2016; 11(10):e0164000. PMID: 27711124.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  54. Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M, Boily MC, Smith MA, Berkhof J, Canfell K, Chesson HW, Burger EA, Choi YH, De Blasio BF, De Vlas SJ, Guzzetta G, Hontelez JAC, Horn J, Jepsen MR, Kim JJ, Lazzarato F, Matthijsse SM, Mikolajczyk R, Pavelyev A, Pillsbury M, Shafer LA, Tully SP, Turner HC, Usher C, Walsh C. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health. 2016 11; 1(1):e8-e17. PMID: 29253379.
    Citations: 50     Fields:    Translation:HumansPHPublic Health
  55. Burger EA, Sy S, Nygård M, Kim JJ. The Cost-Effectiveness of Cervical Self-Sampling to Improve Routine Cervical Cancer Screening: The Importance of Respondent Screening History and Compliance. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):95-103. PMID: 27624639.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  56. Verguet S, Kim JJ, Jamison DT. Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. Pharmacoeconomics. 2016 09; 34(9):913-23. PMID: 27374172.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  57. Pedersen K, Burger EA, Sy S, Kristiansen IS, Kim JJ. Cost-effective management of women with minor cervical lesions: Revisiting the application of HPV DNA testing. Gynecol Oncol. 2016 Nov; 143(2):326-333. PMID: 27542966.
    Citations: 5     Fields:    Translation:HumansCells
  58. McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med. 2016 10; 51(4):507-12. PMID: 27132628.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  59. Burger EA, Lee K, Saraiya M, Thompson TD, Chesson HW, Markowitz LE, Kim JJ. Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines. Cancer. 2016 07 01; 122(13):2057-66. PMID: 27124396.
    Citations: 12     Fields:    Translation:Humans
  60. Cremer ML, Maza M, Alfaro KM, Kim JJ, Ditzian LR, Villalta S, Alonzo TA, Felix JC, Castle PE, Gage JC. Introducing a High-Risk HPV DNA Test Into a Public Sector Screening Program in El Salvador. J Low Genit Tract Dis. 2016 Apr; 20(2):145-50. PMID: 26890683.
    Citations: 4     Fields:    Translation:Humans
  61. Armstrong K, Kim JJ, Halm EA, Ballard RM, Schnall MD. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. 2016 05 01; 122(9):1338-42. PMID: 26929386.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  62. Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, Beaber EF, Onega T, Kim JJ, MacLean CD, Harris K, Yamartino P, Howe K, Pearson L, Feldman S, Brawarsky P, Schapira MM. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med. 2016 Jan; 31(1):52-9. PMID: 26129780.
    Citations: 27     Fields:    Translation:Humans
  63. Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM. Cancer Models and Real-world Data: Better Together. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26538628.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  64. McBain RK, Salhi C, Hann K, Kellie J, Kamara A, Salomon JA, Kim JJ, Betancourt TS. Improving outcomes for caregivers through treatment of young people affected by war: a randomized controlled trial in Sierra Leone. Bull World Health Organ. 2015 Dec 01; 93(12):834-41. PMID: 26668435.
    Citations: 2     Fields:    Translation:Humans
  65. Kim JJ, Campos NG, Sy S, Burger EA, Cuzick J, Castle PE, Hunt WC, Waxman A, Wheeler CM. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis. Ann Intern Med. 2015 Oct 20; 163(8):589-97. PMID: 26414147.
    Citations: 21     Fields:    Translation:HumansPHPublic Health
  66. McBain RK, Salhi C, Hann K, Salomon JA, Kim JJ, Betancourt TS. Costs and cost-effectiveness of a mental health intervention for war-affected young persons: decision analysis based on a randomized controlled trial. Health Policy Plan. 2016 May; 31(4):415-24. PMID: 26345320.
    Citations: 5     Fields:    Translation:Humans
  67. Campos NG, Castle PE, Wright TC, Kim JJ. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage. Int J Cancer. 2015 Nov 01; 137(9):2208-19. PMID: 25943074.
    Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
  68. Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 Jun; 107(6):djv120. PMID: 25957378.
    Citations: 28     Fields:    Translation:HumansPHPublic Health
  69. Kim JJ, Castle PE. Letter to the editor regarding "Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa" by Firnhaber et al. J Low Genit Tract Dis. 2015 Apr; 19(2):e45-6. PMID: 25811272.
    Citations:    Fields:    Translation:Humans
  70. Levin CE, Sharma M, Olson Z, Verguet S, Shi JF, Wang SM, Qiao YL, Jamison DT, Kim JJ. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China. Vaccine. 2015 Jun 04; 33(24):2830-41. PMID: 25770785.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  71. Campos NG, Maza M, Alfaro K, Gage JC, Castle PE, Felix JC, Cremer ML, Kim JJ. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador. Int J Cancer. 2015 Aug 15; 137(4):893-902. PMID: 25639903.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  72. Kiatpongsan S, Kim JJ. Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries. PLoS One. 2014; 9(9):e106836. PMID: 25198104.
    Citations: 8     Fields:    Translation:HumansCells
  73. Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014 Sep 01; 180(5):545-55. PMID: 25081182.
    Citations: 34     Fields:    Translation:HumansCells
  74. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway. J Infect Dis. 2015 Jan 15; 211(2):206-15. PMID: 25057044.
    Citations: 4     Fields:    Translation:Humans
  75. Kim JJ. Practice-based evidence for primary HPV testing in the United States. J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 25038468.
    Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
  76. Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ. Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys. PLoS One. 2014; 9(3):e89974. PMID: 24651645.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  77. Burger EA, Kim JJ. The value of improving failures within a cervical cancer screening program: an example from Norway. Int J Cancer. 2014 Oct 15; 135(8):1931-9. PMID: 24615416.
    Citations: 5     Fields:    Translation:Humans
  78. Soeteman DI, Perry CJ, Kim JJ. The use of comparative effectiveness research in mental healthcare policy and practice. J Comp Eff Res. 2014 Jan; 3(1):1-3. PMID: 24345249.
    Citations:    Fields:    Translation:Humans
  79. Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia. Vaccine. 2013 Dec 31; 31 Suppl 7:H71-9. PMID: 24332299.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  80. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 31; 31 Suppl 7:H1-31. PMID: 24332295.
    Citations: 106     Fields:    
  81. Seoud M, Vaccarella S, El-Kak F, Sancho-Garnier H, Jumaan AO, Kim JJ, Garland SM, Stern PL, LaMontagne DS, Albero G, Bosch FX. Extended Middle East and North Africa: summary recommendations for the prevention of human papillomavirus infections and related cancers including cervical cancer. Vaccine. 2013 Dec 30; 31 Suppl 6:G78-9. PMID: 24331823.
    Citations: 1     Fields:    Translation:Humans
  82. Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Vaccine. 2013 Dec 30; 31 Suppl 6:G65-77. PMID: 24331822.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  83. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 30; 31 Suppl 6:G1-31. PMID: 24331817.
    Citations: 13     Fields:    
  84. Denny LA, Sankaranarayanan R, De Vuyst H, Kim JJ, Adefuye PO, Alemany L, Adewole IF, Awolude OA, Parham G, de Sanjosé S, Bosch FX. Recommendations for cervical cancer prevention in sub-saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F73-4. PMID: 24331750.
    Citations: 16     Fields:    Translation:HumansPHPublic Health
  85. Kim JJ, Campos NG, O'Shea M, Diaz M, Mutyaba I. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa. Vaccine. 2013 Dec 29; 31 Suppl 5:F60-72. PMID: 24331749.
    Citations: 13     Fields:    Translation:Humans
  86. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 29; 31 Suppl 5:F1-31. PMID: 24331745.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  87. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Nov 22; 31 Suppl 8:I1-31. PMID: 24229716.
    Citations: 31     Fields:    Translation:Humans
  88. Lipatova Z, Shah AH, Kim JJ, Mulholland JW, Segev N. Regulation of ER-phagy by a Ypt/Rab GTPase module. Mol Biol Cell. 2013 Oct; 24(19):3133-44. PMID: 23924895.
    Citations: 24     Fields:    Translation:AnimalsCells
  89. Kim JJ, Sharma M, Ortendahl J. Optimal interval for routine cytologic screening in the United States. JAMA Intern Med. 2013 Feb 11; 173(3):241-2. PMID: 23530274.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  90. Soeteman DI, Kim JJ. Cost-effectiveness of psychotherapy for personality disorders: treatment recommendations and implementation. Expert Rev Pharmacoecon Outcomes Res. 2013 Feb; 13(1):73-81. PMID: 23402448.
    Citations: 1     Fields:    Translation:Humans
  91. Canfell K, Chesson H, Kulasingam SL, Berkhof J, Diaz M, Kim JJ. Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine. 2012 Nov 20; 30 Suppl 5:F157-67. PMID: 23199959.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  92. Kiatpongsan S, Campos NG, Kim JJ. Potential benefits of second-generation human papillomavirus vaccines. PLoS One. 2012; 7(11):e48426. PMID: 23144879.
    Citations: 7     Fields:    Translation:HumansCells
  93. Sharma M, Bruni L, Diaz M, Castellsagué X, de Sanjosé S, Bosch FX, Kim JJ. Using HPV prevalence to predict cervical cancer incidence. Int J Cancer. 2013 Apr 15; 132(8):1895-900. PMID: 22965284.
    Citations: 10     Fields:    Translation:HumansCells
  94. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012 Jul; 16(3):175-204. PMID: 22418039.
    Citations: 86     Fields:    Translation:HumansPHPublic Health
  95. Soeteman DI, Miller M, Kim JJ. Modeling the risks and benefits of depression treatment for children and young adults. Value Health. 2012 Jul-Aug; 15(5):724-9. PMID: 22867782.
    Citations: 1     Fields:    Translation:Humans
  96. Goldie SJ, O'Shea M, Kim JJ. Finding consensus on cervical cancer prevention. Am J Public Health. 2012 Jun; 102(6):1050-1; author reply 1051. PMID: 22515848.
    Citations:    Fields:    Translation:Humans
  97. Kim JJ. Effect of quadrivalent HPV vaccination on HPV related disease in women treated for cervical or vulvar/vaginal disease. BMJ. 2012 Mar 27; 344:e1544. PMID: 22454090.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  98. Kim JJ. Opportunities to improve cervical cancer screening in the United States. Milbank Q. 2012 Mar; 90(1):38-41. PMID: 22428691.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  99. Campos NG, Castle PE, Schiffman M, Kim JJ. Policy implications of adjusting randomized trial data for economic evaluations: a demonstration from the ASCUS-LSIL Triage Study. Med Decis Making. 2012 May-Jun; 32(3):400-27. PMID: 22147881.
    Citations: 1     Fields:    Translation:Humans
  100. Kim JJ. The role of cost-effectiveness in U.S. vaccination policy. N Engl J Med. 2011 Nov 10; 365(19):1760-1. PMID: 22010866.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  101. Campos NG, Kim JJ, Castle PE, Ortendahl JD, O'Shea M, Diaz M, Goldie SJ. Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa. Int J Cancer. 2012 Jun 01; 130(11):2672-84. PMID: 21717458.
    Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
  102. Soeteman DI, Busschbach JJ, Verheul R, Hoomans T, Kim JJ. Cost-effective psychotherapy for personality disorders in the Netherlands: the value of further research and active implementation. Value Health. 2011 Mar-Apr; 14(2):229-39. PMID: 21296601.
    Citations: 4     Fields:    Translation:Humans
  103. Kim JJ. Focus on research: weighing the benefits and costs of HPV vaccination of young men. N Engl J Med. 2011 Feb 03; 364(5):393-5. PMID: 21288093.
    Citations: 9     Fields:    Translation:Humans
  104. Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. J Infect Dis. 2011 Mar 15; 203(6):823-7. PMID: 21257737.
    Citations: 12     Fields:    Translation:HumansCells
  105. Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis. 2010 Dec; 10(12):845-52. PMID: 21051295.
    Citations: 58     Fields:    Translation:HumansCellsPHPublic Health
  106. Soeteman DI, Verheul R, Meerman AM, Ziegler U, Rossum BV, Delimon J, Rijnierse P, Thunnissen M, Busschbach JJ, Kim JJ. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands. J Clin Psychiatry. 2011 Jan; 72(1):51-9. PMID: 21034679.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  107. Diaz M, de Sanjose S, Ortendahl J, O'Shea M, Goldie SJ, Bosch FX, Kim JJ. Cost-effectiveness of human papillomavirus vaccination and screening in Spain. Eur J Cancer. 2010 Nov; 46(16):2973-85. PMID: 20638840.
    Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
  108. Soeteman DI, Verheul R, Delimon J, Meerman AM, van den Eijnden E, Rossum BV, Ziegler U, Thunnissen M, Busschbach JJ, Kim JJ. Cost-effectiveness of psychotherapy for cluster B personality disorders. Br J Psychiatry. 2010 May; 196(5):396-403. PMID: 20435967.
    Citations: 10     Fields:    Translation:Humans
  109. Kim JJ, Ortendahl J, Goldie SJ. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States. Ann Intern Med. 2009 Oct 20; 151(8):538-45. PMID: 19841455.
    Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
  110. Kim JJ, Goldie SJ. Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ. 2009 Oct 08; 339:b3884. PMID: 19815582.
    Citations: 67     Fields:    Translation:HumansPHPublic Health
  111. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008 Aug 21; 359(8):821-32. PMID: 18716299.
    Citations: 92     Fields:    Translation:HumansCells
  112. Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ. Mathematical models of cervical cancer prevention in the Asia Pacific region. Vaccine. 2008 Aug 19; 26 Suppl 12:M17-29. PMID: 18945411.
    Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
  113. Kim JJ, Brisson M, Edmunds WJ, Goldie SJ. Modeling cervical cancer prevention in developed countries. Vaccine. 2008 Aug 19; 26 Suppl 10:K76-86. PMID: 18847560.
    Citations: 38     Fields:    Translation:HumansCellsPHPublic Health
  114. Kim JJ. Human papillomavirus vaccination in the UK. BMJ. 2008 Jul 17; 337:a842. PMID: 18640958.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  115. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Vaccine. 2008 Jul 29; 26(32):4015-24. PMID: 18602731.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  116. Kim JJ, Andres-Beck B, Goldie SJ. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer. 2007 Nov 05; 97(9):1322-8. PMID: 17923869.
    Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
  117. Kim JJ. Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men. J Infect Dis. 2007 Oct 15; 196(8):1117-9. PMID: 17955427.
    Citations: 2     Fields:    Translation:HumansCells
  118. Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Vaccine. 2007 Aug 14; 25(33):6257-70. PMID: 17606315.
    Citations: 45     Fields:    Translation:HumansCellsPHPublic Health
  119. Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multiparameter calibration of a natural history model of cervical cancer. Am J Epidemiol. 2007 Jul 15; 166(2):137-50. PMID: 17526866.
    Citations: 52     Fields:    Translation:HumansCells
  120. Woo PP, Kim JJ, Leung GM. What is the most cost-effective population-based cancer screening program for Chinese women? J Clin Oncol. 2007 Feb 20; 25(6):617-24. PMID: 17308266.
    Citations: 14     Fields:    Translation:HumansPHPublic Health
  121. Kwon JS, Carey MS, Goldie SJ, Kim JJ. Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer. J Obstet Gynaecol Can. 2007 Feb; 29(2):131-139. PMID: 17346483.
    Citations: 2     Fields:    Translation:Humans
  122. Kim JJ, Salomon JA, Weinstein MC, Goldie SJ. Packaging health services when resources are limited: the example of a cervical cancer screening visit. PLoS Med. 2006 Nov; 3(11):e434. PMID: 17105337.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  123. Garnett GP, Kim JJ, French K, Goldie SJ. Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/178-86. PMID: 16950005.
    Citations: 45     Fields:    Translation:HumansPHPublic Health
  124. Goldie SJ, Kim JJ, Myers E. Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine. 2006 Aug 31; 24 Suppl 3:S3/164-70. PMID: 16950004.
    Citations: 20     Fields:    Translation:HumansPHPublic Health
  125. Kim JJ. Mathematical model of HPV provides insight into impacts of risk factors and vaccine. PLoS Med. 2006 May; 3(5):e164. PMID: 16573363.
    Citations: 1     Fields:    Translation:HumansCells
  126. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, Solomon D, Goldie SJ. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst. 2006 Jan 18; 98(2):92-100. PMID: 16418511.
    Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
  127. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst. 2005 Jun 15; 97(12):888-95. PMID: 15956650.
    Citations: 27     Fields:    Translation:HumansCellsPHPublic Health
  128. Kim JJ, Leung GM, Woo PP, Goldie SJ. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. J Public Health (Oxf). 2004 Jun; 26(2):130-7. PMID: 15284314.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  129. Goldie SJ, Kim JJ, Wright TC. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet Gynecol. 2004 Apr; 103(4):619-31. PMID: 15051550.
    Citations: 43     Fields:    Translation:HumansCells
  130. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 2002 May 08; 287(18):2382-90. PMID: 11988059.
    Citations: 39     Fields:    Translation:HumansCellsPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (284)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.